$BLNC
Balance Labs, Inc. Stock $blnc

$blnc Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000149315223012585 Filed on April 17, 2023

Income Statement

Concept	2023 Q2	2022 Q4	2022
Revenue		$45.00K	$247.5K
YoY Change		-89.4%	-60.37%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$41.17K	$64.90K	$270.3K
YoY Change	-47.91%	-40.67%	-32.44%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$0.00	$0.00
YoY Change			-100.0%
% of Gross Profit
Operating Expenses	$41.17K	$64.90K	$270.3K
YoY Change	-47.91%	-40.67%	-32.44%
Operating Profit	-$41.17K		-$22.84K
YoY Change	256.98%		-110.18%
Interest Expense	$56.91K	-$165.8K	$231.7K
YoY Change	-2.91%	-95.72%	-126.52%
% of Operating Profit
Other Income/Expense, Net	-$55.58K	-$10.71K	-$745.5K
YoY Change	-71.63%		-27.89%
Pretax Income	-$96.75K	-$196.4K	-$768.4K
YoY Change	-53.36%	-94.49%	-5.07%
Income Tax
% Of Pretax Income
Net Earnings	-$96.75K	-$196.4K	-$768.4K
YoY Change	-53.36%	-94.49%	-3.56%
Net Earnings / Revenue		-436.4%	-310.44%
Basic Earnings Per Share	$0.00		$0.04
Diluted Earnings Per Share	$0.00	-$0.01	$0.04
COMMON SHARES
Basic Shares Outstanding	21.67M shares	21.67M shares	21.67M shares
Diluted Shares Outstanding	21.67M shares		21.67M shares

Balance Sheet

Concept	2023 Q2	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$337.9K	$384.1K	$384.1K
YoY Change	-38.2%	-50.6%	68.8%
Cash & Equivalents	$182.4K	$235.3K	$235.3K
Short-Term Investments	$155.5K	$148.8K	$148.8K
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables		$45.00K	$45.00K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$337.9K	$429.1K	$429.1K
YoY Change	-21.82%	0.81%	0.81%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments			$0.00
YoY Change			-100.0%
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
TOTAL ASSETS
Total Short-Term Assets	$337.9K	$429.1K	$429.1K
Total Long-Term Assets	$0.00	$0.00	$0.00
Total Assets	$337.9K	$429.1K	$429.1K
YoY Change	-56.18%	-57.7%	-57.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.219M	$2.132M	$2.132M
YoY Change	143.38%	150.3%	150.3%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$1.699M	$1.699M	$1.699M
YoY Change	0.0%	0.0%	0.0%
Long-Term Debt Due	$280.0K	$280.0K	$280.0K
YoY Change	0.0%	1.24%	1.24%
Total Short-Term Liabilities	$4.197M	$4.110M	$4.110M
YoY Change	1.9%	4.36%	4.36%
LONG-TERM LIABILITIES
Long-Term Debt	$485.8K	$480.2K	$480.2K
YoY Change	2.39%	2.42%	2.42%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$485.8K	$480.2K	$480.2K
YoY Change	2.39%	2.42%	2.42%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.197M	$4.110M	$4.110M
Total Long-Term Liabilities	$485.8K	$480.2K	$480.2K
Total Liabilities	$4.683M	$4.590M	$4.590M
YoY Change	1.95%	4.15%	5.75%
SHAREHOLDERS EQUITY
Retained Earnings	-$5.158M	-$4.974M
YoY Change	11.28%	18.27%
Common Stock	$2.167K	$2.167K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.345M	-$4.161M	-$4.161M
YoY Change
Total Liabilities & Shareholders Equity	$337.9K	$429.1K	$429.1K
YoY Change	-56.18%	-57.7%	-57.7%

Cashflow Statement

Concept	2023 Q2	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$96.75K	-$196.4K	-$768.4K
YoY Change	-53.36%	-94.49%	-3.56%
Depreciation, Depletion And Amortization		$0.00	$0.00
YoY Change			-100.0%
Cash From Operating Activities	-$38.66K	-$43.46K	$7.753K
YoY Change	-378.73%	1393.47%	-113.63%
INVESTING ACTIVITIES
Capital Expenditures		$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$9.030K	$0.00
YoY Change		-153.56%	-100.0%
Cash From Investing Activities		$9.030K
YoY Change		-153.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		0.000
YoY Change		-100.0%
NET CHANGE
Cash From Operating Activities	-38.66K	-43.46K	$7.753K
Cash From Investing Activities		9.030K
Cash From Financing Activities		0.000
Net Change In Cash	-38.66K	-34.43K	$7.753K
YoY Change	-378.73%	-758.32%	-96.51%
FREE CASH FLOW
Cash From Operating Activities	-$38.66K	-$43.46K	$7.753K
Capital Expenditures		$0.00
Free Cash Flow		-$43.46K	$7.753K
YoY Change		1393.47%	-116.36%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		usd
CY2022Q4	BLNC	Accumulated Losses Of Unconsolidated Investees In Excess Of Investment AccumulatedLossesOfUnconsolidatedInvesteesInExcessOfInvestment		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2021	us-gaap	Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee		usd
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001632121
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent		usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent		usd
CY2022Q4	us-gaap	Due From Related Parties Noncurrent DueFromRelatedPartiesNoncurrent		usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments		usd
CY2022	BLNC	Impairment Of Investment ImpairmentOfInvestment		usd
CY2022	BLNC	Gain On Forgiveness Of Ppp Loan GainOnForgivenessOfPPPLoan		usd
CY2022	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount		usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization		usd
CY2022	us-gaap	Amortization Of Regulatory Asset AmortizationOfRegulatoryAsset		usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2022	us-gaap	Impairment Of Investments ImpairmentOfInvestments		usd
CY2022	BLNC	Investment Received In Exchange For Consulting Services InvestmentReceivedInExchangeForConsultingServices		usd
CY2022	BLNC	Gain On Deconsolidation Of Subsidiary GainOnDeconsolidationOfSubsidiary		usd
CY2022	BLNC	Gain On Forgiveness Of Ppp Loan One GainOnForgivenessOfPPPLoanOne		usd
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
CY2022	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable		usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2022	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation		usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2022	BLNC	Proceeds From Issuance Of Convertible Note Payable Related Party Net ProceedsFromIssuanceOfConvertibleNotePayableRelatedPartyNet		usd
CY2022	BLNC	Proceeds From Short Term Advances Related Parties ProceedsFromShortTermAdvancesRelatedParties		usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	BLNC	Investment At Fair Value Received From Issuance Of Note Receivable InvestmentAtFairValueReceivedFromIssuanceOfNoteReceivable		usd
CY2022	BLNC	Beneficial Conversion Features On Convertible Notes Payable Related Party BeneficialConversionFeaturesOnConvertibleNotesPayableRelatedParty		usd
CY2021Q3	us-gaap	Business Combination Assets And Liabilities Arising From Contingencies Amount Recognized BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized		usd
CY2021Q3	us-gaap	Business Combination Assets And Liabilities Arising From Contingencies Amount Recognized Other Than At Fair Value BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognizedOtherThanAtFairValue		usd
CY2022	us-gaap	Depreciation Depreciation		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	333-202959
CY2022	dei	Entity Registrant Name EntityRegistrantName	BALANCE LABS, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-1146785
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	407 Lincoln Road
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 701
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Miami Beach
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33139
CY2022	dei	City Area Code CityAreaCode	(305)
CY2022	dei	Local Phone Number LocalPhoneNumber	907-7600
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	Yes
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Public Float EntityPublicFloat	518165	usd
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	21674000	shares
CY2022	dei	Auditor Name AuditorName	Assurance Dimensions
CY2022	dei	Auditor Firm AuditorFirmId	5036
CY2022	dei	Auditor Location AuditorLocation	Margate, Florida
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	235311	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	227558	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	45000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	22500	usd
CY2021Q4	BLNC	Allowance For Interest Receivable AllowanceForInterestReceivable	10714	usd
CY2021Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	12932	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	148808	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	550057	usd
CY2022Q4	BLNC	Notes Receivable Unamortized Discount Current NotesReceivableUnamortizedDiscountCurrent	0	usd
CY2021Q4	BLNC	Notes Receivable Unamortized Discount Current NotesReceivableUnamortizedDiscountCurrent	3308	usd
CY2022Q4	BLNC	Notes Receivable Unamortized Allowance Current NotesReceivableUnamortizedAllowanceCurrent	141000	usd
CY2021Q4	BLNC	Notes Receivable Unamortized Allowance Current NotesReceivableUnamortizedAllowanceCurrent	0	usd
CY2021Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	162692	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	429119	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	975739	usd
CY2021Q4	us-gaap	Due From Related Parties Noncurrent DueFromRelatedPartiesNoncurrent	20000	usd
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	18812	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	38812	usd
CY2022Q4	us-gaap	Assets Assets	429119	usd
CY2021Q4	us-gaap	Assets Assets	1014551	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1220017	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1010028	usd
CY2022Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	911659	usd
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	851659	usd
CY2022Q4	BLNC	Due To Related Parties Current Exclude Notes Payable Related Parties Classified DueToRelatedPartiesCurrentExcludeNotesPayableRelatedPartiesClassified	1673558	usd
CY2021Q4	BLNC	Due To Related Parties Current Exclude Notes Payable Related Parties Classified DueToRelatedPartiesCurrentExcludeNotesPayableRelatedPartiesClassified	1673558	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	25000	usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	25000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	0	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	3428	usd
CY2022Q4	BLNC	Due To Related Party Current DueToRelatedPartyCurrent	173192	usd
CY2021Q4	BLNC	Due To Related Party Current DueToRelatedPartyCurrent	169764	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	106850	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	106850	usd
CY2021Q4	BLNC	Accumulated Losses Of Unconsolidated Investees In Excess Of Investment AccumulatedLossesOfUnconsolidatedInvesteesInExcessOfInvestment	101838	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4110276	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3938697	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	19845	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	31185	usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	480155	usd
CY2021Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	468815	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	480155	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	468815	usd
CY2022Q4	us-gaap	Liabilities Liabilities	4590431	usd
CY2021Q4	us-gaap	Liabilities Liabilities	4407512	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21674000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21674000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21674000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21674000	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2167	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	2167	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	810048	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	810048	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4973527	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4205176	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4161312	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-3392961	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4161312	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3392961	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	429119	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1014551	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	247500	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	624590	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	21236	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	29963	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	139263	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	104729	usd
CY2022	us-gaap	Salaries And Wages SalariesAndWages	49837	usd
CY2021	us-gaap	Salaries And Wages SalariesAndWages	145472	usd
CY2022	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	60000	usd
CY2021	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	120000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	270336	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	400164	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-22836	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	224426	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-401250	usd
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-822533	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	151714	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-47255	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-13591	usd
CY2022	BLNC	Accreted Interest Income And Interest Income On Note Receivable AccretedInterestIncomeAndInterestIncomeOnNoteReceivable	3311	usd
CY2021	BLNC	Accreted Interest Income And Interest Income On Note Receivable AccretedInterestIncomeAndInterestIncomeOnNoteReceivable	52919	usd
CY2022	us-gaap	Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee	83064	usd
CY2022	us-gaap	Interest Expense InterestExpense	231671	usd
CY2021	us-gaap	Interest Expense InterestExpense	244291	usd
CY2021	BLNC	Impairment Of Investment ImpairmentOfInvestment	-195000	usd
CY2021	BLNC	Gain On Forgiveness Of Ppp Loan GainOnForgivenessOfPPPLoan	34759	usd
CY2021	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	153907	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-745515	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1033830	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-768351	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-809404	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-12708	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-768351	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-796696	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21674000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21674000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21674000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21674000	shares
CY2022	us-gaap	Profit Loss ProfitLoss	-768351	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-809404	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	14768	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	14903	usd
CY2022	BLNC	Amortization Of Expense On Note Receivable AmortizationOfExpenseOnNoteReceivable	3308	usd
CY2021	BLNC	Amortization Of Expense On Note Receivable AmortizationOfExpenseOnNoteReceivable	39692	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	80	usd
CY2021	us-gaap	Amortization Of Regulatory Asset AmortizationOfRegulatoryAsset	1336	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	151714	usd
CY2021	us-gaap	Impairment Of Investments ImpairmentOfInvestments	195000	usd
CY2022	BLNC	Equity Method Investment Summarized Financial Information Net Loss EquityMethodInvestmentSummarizedFinancialInformationNetLoss	43812	usd
CY2021	BLNC	Equity Method Investment Summarized Financial Information Net Loss EquityMethodInvestmentSummarizedFinancialInformationNetLoss	24188	usd
CY2021	BLNC	Investment Received In Exchange For Consulting Services InvestmentReceivedInExchangeForConsultingServices	-352090	usd
CY2022	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	-401249	usd
CY2021	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	-822533	usd
CY2021	BLNC	Gain On Deconsolidation Of Subsidiary GainOnDeconsolidationOfSubsidiary	153907	usd
CY2021	BLNC	Gain On Forgiveness Of Ppp Loan One GainOnForgivenessOfPPPLoanOne	34500	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	83064	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	22500	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	22500	usd
CY2022	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-2218	usd
CY2021	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	12168	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-25000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	209989	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	180065	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	60000	usd
CY2021	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	120000	usd
CY2022	BLNC	Increase Decrease In Accumulated Income Losses Of Unconsolidated Investees In Excess Of Investment IncreaseDecreaseInAccumulatedIncomeLossesOfUnconsolidatedInvesteesInExcessOfInvestment	-1226	usd
CY2021	BLNC	Increase Decrease In Accumulated Income Losses Of Unconsolidated Investees In Excess Of Investment IncreaseDecreaseInAccumulatedIncomeLossesOfUnconsolidatedInvesteesInExcessOfInvestment	15740	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7753	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-56896	usd
CY2021	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	141000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9500	usd
CY2021	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	53178	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-203678	usd
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	25000	usd
CY2021	BLNC	Proceeds From Issuance Of Convertible Note Payable Related Party Net ProceedsFromIssuanceOfConvertibleNotePayableRelatedPartyNet	50000	usd
CY2021	BLNC	Proceeds From Short Term Advances Related Parties ProceedsFromShortTermAdvancesRelatedParties	407500	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	482500	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7753	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	221926	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	227558	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5632	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	235311	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	227558	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	900	usd
CY2021	BLNC	Investment At Fair Value Received From Issuance Of Note Receivable InvestmentAtFairValueReceivedFromIssuanceOfNoteReceivable	43000	usd
CY2021	BLNC	Beneficial Conversion Features On Convertible Notes Payable Related Party BeneficialConversionFeaturesOnConvertibleNotesPayableRelatedParty	3799	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2587356	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	3799	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-809404	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3392961	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3392961	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-768351	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4161312	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4161312	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-768351	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4161312	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	2000	usd
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	2000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_zXxRKNJFFsuk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_864_zDVHVEzZ7P4h">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Estimates may include those pertaining to stock-based compensation, depreciable lives of fixed assets and deferred tax assets. Actual results could materially differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	us-gaap	Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee	83064	usd
CY2022Q4	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	1000000	shares
CY2022Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1000000	usd
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.00
CY2022Q4	us-gaap	Investment Owned Balance Shares InvestmentOwnedBalanceShares	531539	shares
CY2022	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1 for 3.763243
CY2022Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	148808	usd
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.28
CY2022	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	401250	usd
CY2021	BLNC	Impairment Of Investment ImpairmentOfInvestment	-195000	usd
CY2022Q4	us-gaap	Investments Investments	0	usd
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	53178	usd
CY2021Q3	BLNC	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Trademark BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTrademark	2835	usd
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets	9500	usd
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	65513	usd
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	56489	usd
CY2021Q3	BLNC	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Due To Parent Company BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDueToParentCompany	25764	usd
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther	25000	usd
CY2021Q3	BLNC	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Notes Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayable	112167	usd
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	219420	usd
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	153907	usd
CY2021Q3	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	153907	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_zazLsleKHqVf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_866_zrCr6dEo4o69">Concentration of Credit Risk</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash, cash equivalents and marketable securities. As of December 31, 2022, the carrying value of marketable securities was $<span id="xdx_902_eus-gaap--MarketableSecurities_iI_pp0p0_c20221231_zJjJ62REFrJd" title="Marketable securities">148,808</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, which consist of common shares held in one (1) investment which currently is trading on the Over-the-Counter Bulletin Board (OTCBB). At December 31, 2022, the Company owned <span id="xdx_904_ecustom--NumberOfSharesOwnedByFairValueOfInvestment_c20220101__20221231_zfhYfTlnyMTl" title="Shares owned by fair value of investment">531,539</span> shares after a reverse stock split adjustment of <span id="xdx_90B_eus-gaap--StockholdersEquityReverseStockSplit_c20220101__20221231_zn2NktO211dc" title="Reverse stock split">1 for 3.763243</span> and the fair value of the investment in EZFill Holdings, Inc. was reported on the balance sheet as Investment at fair value - related party totaling $<span id="xdx_90E_eus-gaap--MarketableSecurities_iI_pp0p0_c20221231_zG2DioHQLcl4" title="Marketable securities">148,808</span> ($<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_c20221231_zMfVN4n2txf8" title="Share issued price per share">0.28</span>/share). Recorded an adjustment of $<span id="xdx_908_eus-gaap--DebtSecuritiesUnrealizedGainLoss_c20220101__20221231_zs9NwptdqyEl" title="Unrealized loss on securities">401,250</span> for the twelve months ending December 31, 2022, as unrealized loss on securities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	148808	usd
CY2022	BLNC	Number Of Shares Owned By Fair Value Of Investment NumberOfSharesOwnedByFairValueOfInvestment	531539	shares
CY2022	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1 for 3.763243
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	148808	usd
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.28
CY2022	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	401250	usd
CY2021	BLNC	Impairment Of Investment ImpairmentOfInvestment	-195000	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1740	usd
CY2021	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	4331	usd
CY2022	us-gaap	Property Plant And Equipment Estimated Useful Lives PropertyPlantAndEquipmentEstimatedUsefulLives	three to five years
CY2021	us-gaap	Depreciation Depreciation	0	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	BLNC	Notes Receivable Unamortized Allowance Current NotesReceivableUnamortizedAllowanceCurrent	141000	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	10714	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	19845	usd
CY2022Q4	BLNC	Due To Related Parties Current Exclude Notes Payable Related Parties Classified DueToRelatedPartiesCurrentExcludeNotesPayableRelatedPartiesClassified	1673558	usd
CY2021Q4	BLNC	Due To Related Parties Current Exclude Notes Payable Related Parties Classified DueToRelatedPartiesCurrentExcludeNotesPayableRelatedPartiesClassified	1673558	usd
CY2016Q3	us-gaap	Area Of Land AreaOfLand	2200	sqft
CY2017Q3	BLNC	Monthly Base Rent MonthlyBaseRent	7741	usd
CY2018	BLNC	Monthly Base Rent MonthlyBaseRent	7973	usd
CY2016Q3	BLNC	Percentage Of Additional Base Rent PercentageOfAdditionalBaseRent	0.50	pure
CY2016Q3	us-gaap	Lease Cost LeaseCost	16725	usd
CY2021	BLNC	Impairment Of Investment ImpairmentOfInvestment	-195000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	247534	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	232327	usd
CY2022Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Trading Securities DeferredTaxAssetsUnrealizedLossesOnTradingSecurities	120135	usd
CY2021Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Trading Securities DeferredTaxAssetsUnrealizedLossesOnTradingSecurities	84399	usd
CY2022Q4	BLNC	Deferred Tax Assets Impairment Of Investments DeferredTaxAssetsImpairmentOfInvestments	324364	usd
CY2021Q4	BLNC	Deferred Tax Assets Impairment Of Investments DeferredTaxAssetsImpairmentOfInvestments	208471	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	286626	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	339152	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	978659	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	864349	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.0435	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.0435	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.0575	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.0575	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.311	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.311	pure
CY2021	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	As of December 31, 2021, the Company had approximately $1,338,000 of federal and state net operating loss carryovers (“NOLs”). From this amount, $711,000 expire after 20 years, and can be carried back 2 years, according to the old tax law, while $627,000 can be carried forward indefinitely and cannot be carried back, in accordance with the new tax rules.
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	114310	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	251726	usd

Files In Submission

Name	View Source	Status
0001493152-23-012585-index-headers.html	Edgar Link	pending
0001493152-23-012585-index.html	Edgar Link	pending
0001493152-23-012585.txt	Edgar Link	pending
0001493152-23-012585-xbrl.zip	Edgar Link	pending
blnc-20221231.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
blnc-20221231_def.xml	Edgar Link	unprocessable
blnc-20221231_cal.xml	Edgar Link	unprocessable
blnc-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
blnc-20221231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BLNC
Balance Labs, Inc. Stock $blnc

2023 Q2 Form 10-K Financial Statement

#000149315223012585 Filed on April 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BLNC Balance Labs, Inc. Stock $blnc

2023 Q2 Form 10-K Financial Statement

#000149315223012585 Filed on April 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BLNC
Balance Labs, Inc. Stock $blnc